Simplex Trading
FULC icon

Simplex Trading’s Fulcrum Therapeutics FULC Stock Holding History

Simplex Trading’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$322K Buy
41,940
+33,926
+423% +$315K ﹤0.01% 3749
2025
Q4 		$90.6K Sell
8,014
-4,786
-37% -$48.7K ﹤0.01% 5092
2025
Q3 		$117K Sell
12,800
-96,565
-88% -$699K ﹤0.01% 5558
2025
Q2 		$752K Buy
109,365
+106,339
+3,514% +$569K ﹤0.01% 3086
2025
Q1 		$8K Sell
3,026
-7,429
-71% -$27.3K ﹤0.01% 7237
2024
Q4 		$49K Sell
10,455
-39,309
-79% -$145K ﹤0.01% 5884
2024
Q3 		$177K Sell
49,764
-7,369
-13% -$54.7K ﹤0.01% 4633
2024
Q2 		$354K Buy
57,133
+26,394
+86% +$200K ﹤0.01% 4037
2024
Q1 		$290K Buy
+30,739
New +$274K ﹤0.01% 4442
2023
Q4 		– Sell
-25,424
Closed -$113K – 9134
2023
Q3 		$112K Buy
25,424
+24,976
+5,575% +$109K ﹤0.01% 4976
2023
Q2 		$1K Sell
448
-792
-64% -$2.33K ﹤0.01% 8616
2023
Q1 		$3K Buy
+1,240
New +$11.1K ﹤0.01% 8303
2022
Q3 		– Sell
-14,005
Closed -$100K – 10228
2022
Q2 		$68K Sell
14,005
-2,622
-16% -$25.6K ﹤0.01% 6070
2022
Q1 		$393K Buy
+16,627
New +$235K ﹤0.01% 4169

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Simplex Trading's FULC Position: Q1 2026 in Review

Simplex Trading increased its Fulcrum Therapeutics (FULC) stake by 423% in Q1 2026, buying an estimated $315K and bringing the position to 41,940 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #3749.

Simplex Trading first reported a position in FULC in Q1 2022 and has held it in 14 quarters since. The position peaked at $752K in Q2 2025. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Simplex Trading held 41,940 shares of Fulcrum Therapeutics worth $322K as of Q1 2026.
  • Simplex Trading bought 33,926 Fulcrum Therapeutics shares in Q1 2026, an estimated $315K.
  • Fulcrum Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3749 holding.
  • Simplex Trading first reported a position in Fulcrum Therapeutics in Q1 2022 and has held it in 14 quarters since.
  • Simplex Trading's Fulcrum Therapeutics position peaked at $752K in Q2 2025.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.